Skip to main content
OpenTrials

Clinical trial condition

Coronaviridae Infections

Explore clinical trials studying Coronaviridae Infections. Study availability and eligibility vary by location and protocol.

5,124 public trials 293 recruiting studies
Refine in advanced search Browse all conditions

Coronaviridae Infections trial results

Completed

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

NCT04401436

Conditions
COVID-19, Cardiovascular Diseases, Coronaviridae Infections, +22 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Health Research Institute: Washington Hospital Medical Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Hollywood, Florida, United States
  • GSK Investigational Site Peoria, Illinois, United States
  • GSK Investigational Site Bruce, Australian Capital Territory, Australia
View all 17 locations
View Trial Details
Completed

COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

NCT05289037

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic Birmingham, Alabama, United States
  • University of California, San Diego (UCSD) - Antiviral Research Center (AVRC) San Diego, California, United States
  • Zuckerberg San Francisco General Hospital, UCSF Positive Health Program San Francisco, California, United States
  • George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
View all 22 locations
View Trial Details
Completed

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

NCT06864143

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +13 more
Locations
  • Headlands Research Scottsdale Scottsdale, Arizona, United States
  • Artemis Research (Headlands) San Diego, California, United States
  • Clinical Research Atlanta (Headlands) Stockbridge, Georgia, United States
  • Velocity Clinical Research, Boise Meridian, Idaho, United States
View all 17 locations
View Trial Details
Completed

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

NCT03474965

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Joe DiMaggio Childrens Hospital Hollywood, Florida, United States
View all 35 locations
View Trial Details
Completed

Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19

NCT04347239

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Disease 2019, +10 more
Locations
  • Advanced Cardiovascular, LLC Alexander City, Alabama, United States
  • St. Jude Medical Center Fullerton, California, United States
  • UCLA Los Angeles, California, United States
  • James A. Haley Veterans' Hospital Tampa, Florida, United States
View all 18 locations
View Trial Details

Related conditions